AI assistant
Transgene Capital/Financing Update 2021
1715_rns_2021-07-06_7512561b-981a-47c0-bd39-1c0941a43bed.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
PRESS RELEASE
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2021
Strasbourg, July 06, 2021 – 06:00 pm CET
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2021, the following resources were managed through the liquidity account:
- 175,000 shares
- € 312,618.00
In the first half of 2021, a total of:
| Purchases | 528,545 shares |
€ 1,354,956 | 998 market transactions |
|---|---|---|---|
| Sales | 548,545 shares |
€ 1,389,681 | 1,212 market transactions |
It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:
Cash balance of the liquidity contract: € 500,000.00
At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
- 164,183 shares
- € 246,158.00
Contacts
Transgene:
Lucie Larguier Director Corporate Communications & IR +33 (0)3 88 27 91 04 [email protected]